SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001493152-21-019686
Filing Date
2021-08-13
Accepted
2021-08-13 15:50:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13d.htm SC 13D 55706
  Complete submission text file 0001493152-21-019686.txt   57094
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Subject) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92776 | Film No.: 211171911
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTEC PARENT, INC. 12 HARTOM ST., HAR HOTZVIM JERUSALEM L3 9777512
Business Address
Newman Michael James (Filed by) CIK: 0001876315 (see all company filings)

Type: SC 13D